Myocarditis
What's New
Last Posted: Mar 07, 2024
- Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
Juan Pablo Kaski et al. Eur Heart J 2024 - Genetic Contribution to End-Stage Cardiomyopathy Requiring Heart Transplantation.
Yuri Kim et al. Circ Genom Precis Med 2023 e004062 - Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis.
Abdallah Alami et al. BMJ Open 2023 6 (6) e065687 - Effectiveness of BNT162b2 after extending the primary series dosing interval in children and adolescents aged 5-17.
Francisco Tsz Tsun Lai et al. Nature communications 2023 14(1) 1845 - Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada
SA Buchan et al, JAMA Pediatrics, February 27, 2023 - Sudden arrhythmic death and cardiomyopathy are important causes of sudden cardiac death in the UK: results from a national coronial autopsy database.
Mary N Sheppard et al. Histopathology 2023 - DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort.
Francesca Di Lorenzo et al. International journal of molecular sciences 2023 24(3) - Safety of bivalent omicron-containing mRNA-booster vaccines: a nationwide cohort study
NW Andersson et al, MEDRXIV, January 23, 2023 - Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis.
Lai Francisco Tsz Tsun et al. Journal of the American College of Cardiology 2022 12 (24) 2255-2265 - A Machine-Learning Model for the Prognostic Role of C-Reactive Protein in Myocarditis.
Baritussio Anna et al. Journal of clinical medicine 2022 11(23)
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 27, 2024
- Content source: